Erez Eitan

Advisor at Cogentis Therapeutics

Dr. Eitan was the first to study exosomes at the National Institute on Aging (NIA). As a pioneer in the field, Dr. Eitan has developed novel methodologies and published over 27 peer reviewed articles. During his recent tenure as senior scientist in a leading diagnostic company, Dr. Eitan has led research collaborations with several pharmaceutical companies. He currently leading the science at NeuroDex who is collaborating with us to develop a companion diagnostic for CT526.

Timeline

  • Advisor

    Current role